\n\t\t\tExpert insights, analysis and smart data help you cut through the noise to spot trends,\n\t\t\trisks and opportunities.\n\t\t\n\t\tJoin over 300,000 Finance professionals who already subscribe to the FT.
Expert insights, analysis and smart data help you cut through the noise to spot trends, risks and opportunities.Try full digital access and see why over 1 million readers subscribe to the FT.
Expert insights, analysis and smart data help you cut through the noise to spot trends, risks and opportunities.Try full digital access and see why over 1 million readers subscribe to the FTIreland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
NI healthcare pressures contributed to 300 excess deathsThere have been 300 more deaths than expected across Northern Ireland in the past 10 weeks, many as a result of acute pressures on the health system - mlchealth
Read more »
South Scotland golden eagle project hits milestone with six new chicksThe population in Southern Scotland hits 39, the highest number in the area in 300 years.
Read more »
Carolean era: This is what it will be known as under King Charles III as reign beginsCarolean era: This is what and why it will be known as under King Charles III as his reign begins
Read more »
Accumulation of copy number alterations and clinical progression across advanced prostate cancer - Genome MedicineBackground Genomic copy number alterations commonly occur in prostate cancer and are one measure of genomic instability. The clinical implication of copy number change in advanced prostate cancer, which defines a wide spectrum of disease from high-risk localised to metastatic, is unknown. Methods We performed copy number profiling on 688 tumour regions from 300 patients, who presented with advanced prostate cancer prior to the start of long-term androgen deprivation therapy (ADT), in the control arm of the prospective randomised STAMPEDE trial. Patients were categorised into metastatic states as follows; high-risk non-metastatic with or without local lymph node involvement, or metastatic low/high volume. We followed up patients for a median of 7 years. Univariable and multivariable Cox survival models were fitted to estimate the association between the burden of copy number alteration as a continuous variable and the hazard of death or disease progression. Results The burden of copy number alterations positively associated with radiologically evident distant metastases at diagnosis (P=0.00006) and showed a non-linear relationship with clinical outcome on univariable and multivariable analysis, characterised by a sharp increase in the relative risk of progression (P=0.003) and death (P=0.045) for each unit increase, stabilising into more modest increases with higher copy number burdens. This association between copy number burden and outcome was similar in each metastatic state. Copy number loss occurred significantly more frequently than gain at the lowest copy number burden quartile (q=4.1 × 10−6). Loss of segments in chromosome 5q21-22 and gains at 8q21-24, respectively including CHD1 and cMYC occurred more frequently in cases with higher copy number alteration (for either region: Kolmogorov–Smirnov distance, 0.5; adjusted P|0.0001). Copy number alterations showed variability across tumour regions in the same prostate. This variance associated with increased risk
Read more »
US warns of sanctions for buyers that ignore price cap on Russian oil\n\t\t\tExpert insights, analysis and smart data help you cut through the noise to spot trends,\n\t\t\trisks and opportunities.\n\t\t\n\t\tJoin over 300,000 Finance professionals who already subscribe to the FT.
Read more »